• No Pain, Swift Gains

    5 monthes ago - By Surgical Aesthetics Magazine

    A new neurotoxin with a fast onset of action and shorter duration of effect is in development for aesthetics and pain relief.By Inga Hansen While the aesthetics industry has been focused on new botulinum toxin products and dosing strategies geared toward increasing longevity of results, a new company Bonti has been developing EB-001, a serotype E botulinum toxin that moves in the opposite direction. “This molecule is very similar to the existing botulinum toxin serotype A products in terms of mechanism of action, however, it has two differentiating factors. One, it takes effect much...
    Read more ...